Literature DB >> 28179331

Preoperative Platelet-to-Albumin Ratio Predicts Prognosis of Patients with Pancreatic Ductal Adenocarcinoma After Pancreatic Resection.

Yoshihiro Shirai1,2, Hiroaki Shiba3, Koichiro Haruki3, Takashi Horiuchi3,2, Nobuhiro Saito3,2, Yuki Fujiwara3, Taro Sakamoto3, Tadashi Uwagawa3,4, Katsuhiko Yanaga3.   

Abstract

BACKGROUND: The aim of this study was to evaluate a novel prognostic value of preoperative platelet-to-albumin ratio (PAR) in patients resected for pancreatic cancer. PATIENTS AND METHODS: A total of 107 patients who underwent pancreatic resection for pancreatic cancer were studied. The patients were divided into two groups as PAR ≥46.4×103 or <46.4×103 Survival data were analyzed using the log-rank test for univariate analysis and Cox proportional hazards for multivariate analysis.
RESULTS: The PAR was a significant prognostic index on univariate analysis for disease-free survival (DFS) and overall survival (OS). The PAR retained its significance on multivariate analysis for OS (hazard ratio(HR)=2.344, 95% confidence interval(CI)=1.188-4.624, p=0.014) along with tumor differentiation and nodal involvement. PAR was a significant independent prognostic index for poor DFS on multivariate analysis (HR=1.971, 95% CI=1.128-3.444, p=0.017).
CONCLUSION: The preoperative PAR is a novel significant independent prognostic index for DFS and OS in patients after pancreatic resection with curative intent. Copyright
© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  PAR; Platelet to albumin ratio; inflammation; pancreatic cancer; pancreatic resection; prognostic index

Mesh:

Substances:

Year:  2017        PMID: 28179331     DOI: 10.21873/anticanres.11378

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  19 in total

1.  Clinical Impact of Platelet-to-albumin Ratio on Esophageal Cancer Patients Who Receive Curative Treatment.

Authors:  Toru Aoyama; Miwha Ju; Keisuke Komori; Hiroshi Tamagawa; Ayako Tamagawa; Junya Morita; Itaru Hashimoto; Tetsushi Ishiguro; Atsushi Onodera; Haruhiko Cho; Kazuya Endo; Shizune Onuma; Kazuki Kano; Kentaro Hara; Momoko Fukuda; Takashi Oshima; Norio Yukawa; Yasushi Rino
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

2.  Low Systemic Inflammation Response Index Predicts Good Prognosis in Locally Advanced Pancreatic Carcinoma Patients Treated with Concurrent Chemoradiotherapy.

Authors:  Erkan Topkan; Huseyin Mertsoylu; Ahmet Kucuk; Ali Ayberk Besen; Ahmet Sezer; Duygu Sezen; Yasemin Bolukbasi; Ugur Selek; Berrin Pehlivan
Journal:  Gastroenterol Res Pract       Date:  2020-07-30       Impact factor: 2.260

3.  Prognostic Value of Pretreatment Albumin-to-Alkaline Phosphatase Ratio in Extensive-Disease Small-Cell Lung Cancer: A Retrospective Cohort Study.

Authors:  Shaozhang Zhou; Huiling Wang; Wei Jiang; Qitao Yu; Aiping Zeng
Journal:  Cancer Manag Res       Date:  2020-03-18       Impact factor: 3.989

4.  Racial and ethnic disparities in a state-wide registry of patients with pancreatic cancer and an exploratory investigation of cancer cachexia as a contributor to observed inequities.

Authors:  Jennifer B Permuth; Ashley Clark Daly; Daniel Jeong; Jung W Choi; Miles E Cameron; Dung-Tsa Chen; Jamie K Teer; Tracey E Barnett; Jiannong Li; Benjamin D Powers; Nagalakshmi B Kumar; Thomas J George; Karla N Ali; Tri Huynh; Shraddha Vyas; Clement K Gwede; Vani N Simmons; Pamela J Hodul; Estrella M Carballido; Andrew R Judge; Jason B Fleming; Nipun Merchant; Jose G Trevino
Journal:  Cancer Med       Date:  2019-05-09       Impact factor: 4.452

5.  Prognostic value of γ-glutamyltransferase-to-albumin ratio in patients with pancreatic ductal adenocarcinoma following radical surgery.

Authors:  Shuo Li; Huaxiang Xu; Chuntao Wu; Wenquan Wang; Wei Jin; Heli Gao; Hao Li; Shirong Zhang; Jinzhi Xu; Wuhu Zhang; Shuaishuai Xu; Tianjiao Li; Quanxing Ni; Xianjun Yu; Liang Liu
Journal:  Cancer Med       Date:  2019-01-10       Impact factor: 4.452

6.  The preoperative platelet to albumin ratio predicts the prognosis of hepatocellular carcinoma patients without portal hypertension after liver resection.

Authors:  Chuan Li; Wei Peng; Xiao-Yun Zhang; Tian-Fu Wen; Li-Ping Chen
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

7.  Independent effect of postoperative neutrophil-to-lymphocyte ratio on the survival of pancreatic ductal adenocarcinoma with open distal pancreatosplenectomy and its nomogram-based prediction.

Authors:  Ning Pu; Hanlin Yin; Guochao Zhao; Abulimiti Nuerxiati; Dansong Wang; Xuefeng Xu; Tiantao Kuang; Dayong Jin; Wenhui Lou; Wenchuan Wu
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

8.  Comparison of prognostic prediction between nomogram based on lymph node ratio and AJCC 8th staging system for patients with resected pancreatic head carcinoma: a SEER analysis.

Authors:  Ning Pu; Jianang Li; Yaolin Xu; Wanling Lee; Yuan Fang; Xu Han; Guochao Zhao; Lei Zhang; Abulimiti Nuerxiati; Hanlin Yin; Wenchuan Wu; Wenhui Lou
Journal:  Cancer Manag Res       Date:  2018-02-05       Impact factor: 3.989

9.  Alkaline Phosphatase-To-Albumin Ratio as a Prognostic Indicator in Pancreatic Ductal Adenocarcinoma after Curative Resection.

Authors:  Ning Pu; Shanshan Gao; Yadong Xu; Guochao Zhao; Yang Lv; Abulimiti Nuerxiati; Jian-Ang Li; Dansong Wang; Xuefeng Xu; Tiantao Kuang; Xiaolin Wang; Wenhui Lou; Lingxiao Liu; Wenchuan Wu
Journal:  J Cancer       Date:  2017-09-20       Impact factor: 4.207

10.  High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy.

Authors:  Veysel Haksoyler; Erkan Topkan
Journal:  Ther Clin Risk Manag       Date:  2021-07-05       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.